rs35877720

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001379610.1(SPINK1):​c.36G>C​(p.Leu12Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0053 in 1,613,622 control chromosomes in the GnomAD database, including 418 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L12S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.029 ( 238 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 180 hom. )

Consequence

SPINK1
NM_001379610.1 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.85

Publications

5 publications found
Variant links:
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]
SPINK1 Gene-Disease associations (from GenCC):
  • hereditary chronic pancreatitis
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • tropical pancreatitis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001957178).
BP6
Variant 5-147831542-C-G is Benign according to our data. Variant chr5-147831542-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 36781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0989 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK1NM_001379610.1 linkc.36G>C p.Leu12Phe missense_variant Exon 1 of 4 ENST00000296695.10 NP_001366539.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK1ENST00000296695.10 linkc.36G>C p.Leu12Phe missense_variant Exon 1 of 4 1 NM_001379610.1 ENSP00000296695.5 P00995
SPINK1ENST00000510027.2 linkc.36G>C p.Leu12Phe missense_variant Exon 1 of 3 3 ENSP00000427376.1 D6RIU5

Frequencies

GnomAD3 genomes
AF:
0.0290
AC:
4419
AN:
152160
Hom.:
238
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00858
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0277
GnomAD2 exomes
AF:
0.00745
AC:
1866
AN:
250630
AF XY:
0.00514
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.00394
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00441
GnomAD4 exome
AF:
0.00283
AC:
4131
AN:
1461344
Hom.:
180
Cov.:
30
AF XY:
0.00240
AC XY:
1743
AN XY:
726996
show subpopulations
African (AFR)
AF:
0.101
AC:
3370
AN:
33454
American (AMR)
AF:
0.00490
AC:
219
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39630
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53220
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.000115
AC:
128
AN:
1111836
Other (OTH)
AF:
0.00648
AC:
391
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
199
398
598
797
996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0291
AC:
4427
AN:
152278
Hom.:
238
Cov.:
33
AF XY:
0.0276
AC XY:
2057
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.101
AC:
4215
AN:
41554
American (AMR)
AF:
0.00850
AC:
130
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68032
Other (OTH)
AF:
0.0303
AC:
64
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
201
403
604
806
1007
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00468
Hom.:
28
Bravo
AF:
0.0331
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0978
AC:
431
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00919
AC:
1116
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Benign:6
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Feb 24, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 06, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27086061, 17568390, 20981092, 28994706, 17274009, 17003641) -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T;.
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.0020
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.9
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.24
Sift
Uncertain
0.024
D;D
Sift4G
Uncertain
0.038
D;D
Polyphen
0.64
P;.
Vest4
0.16
MutPred
0.77
Loss of helix (P = 0.1299);Loss of helix (P = 0.1299);
MVP
0.85
MPC
0.16
ClinPred
0.0089
T
GERP RS
3.1
PromoterAI
0.044
Neutral
Varity_R
0.080
gMVP
0.63
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35877720; hg19: chr5-147211105; API